FOXO1

FOXO1 is a Forkhead box O transcription factor regulated by insulin/PI3K/Akt signaling, and it coordinates gene programs controlling metabolism, apoptosis, cell-cycle arrest, oxidative-stress resistance, and DNA repair^[1]. Mechanistically, insulin or growth-factor stimulation phosphorylates FOXO proteins through Akt, drives nuclear export, and suppresses FOXO-dependent transcription^[1]. In ovarian granulosa cells, FSH and IGF-1 activate PI3K/AKT signaling downstream through FOXO1, supporting gene expression linked to follicle maturation^[2]. In diabetes models, FOXO1 regulates hepatic glucose production, and selective FOXO1 inhibition improved insulin sensitivity and glucose control in db/db mice without weight gain^[3]. Compared with related isoforms, mammals contain FOXO1, FOXO3, FOXO4, and FOXO6, but FoxO1-null mice die at embryonic day 10.5 from angiogenesis defects, while FoxO3- and FoxO4-null mice are viable^[1]. This isoform distinction supports FOXO1-focused experimental designs when metabolic control, hepatic glucose output, or developmental vascular phenotypes are primary endpoints^[1][3]. For experimental applications, compound 10 showed higher FOXO1 selectivity than AS1842856 and served as a superior tool molecule for investigating FOXO1 function in vitro and in vivo^[3].